Article Information
History
- June 19, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Omonigho Aisagbonhi, MD., Ph.D.1,2,*,
- Tony Bui, BS.1,2,3,
- Hailee St. Louis, MD.1,
- Donald Pizzo, Ph.D.1,
- Morgan Meads, BS.1,2,3,
- Megan Mulholland, BS.1,2,3,
- Robert Morey, Ph.D.1,3,
- Celestine Magallanes, BS4,
- Leah Lamale-Smith, MD4,
- Louise C. Laurent, MD, Ph.D.4,
- Marni B. Jacobs, Ph.D.2,4,
- Kathleen M. Fisch, Ph.D.2,3,4,5 and
- Mariko Horii, MD1,2,3
- 1Department of Pathology, University of California, San Diego, La Jolla, California, USA
- 2Center for Perinatal Discovery, University of California, San Diego, La Jolla, California, USA
- 3Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, California, USA
- 4Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Diego, La Jolla, California, USA
- 5Center for Computational Biology and Bioinformatics, University of California, San Diego, La Jolla, California, USA
- ↵*Corresponding author: Address: 9444 Medical Center Drive (1-200) La Jolla, CA 92037 E-mail: oaisagbonhi{at}health.ucsd.edu Phone: 858-657-5464, Fax: 858-657-5495
Posted June 19, 2023.
RNA sequencing identifies human placental IL3RA as a potential predictor of adverse cardiovascular outcomes in patients with severe preeclampsia
